Skip to content

Friday, May 2, 2025

New Economy World

The world economy is the economy of all humans in the world

Search

Home
Blog
Finance News
Insurance
Investing
Construction
Property
Stock
Tech
Venture Capital

Home
Stock
Cytokinetics stock falls on FDA delay for heart drug

Cytokinetics stock falls on FDA delay for heart drug

Cytokinetics stock falls on FDA delay for heart drug#Cytokinetics #stock #falls #FDA #delay #heart #drug

Tags: Cytokinetics, delay, Drug, Falls, FDA, Heart, stock

Post navigation

Vistra: Valuation Reset After AI Euphoria – A Prudent Hold

ZIM Integrated Shipping: Prime Days May Be Over For Now

Search

Finance and Economics

Recent Posts

Tri Pointe Homes: The Firm's Deterioration Does Not Negate The Upside That It Offers

SmartRent Receives Continued Listing Standard Notice from NYSE

ASR: Growth Engines Firing In Colombia And Puerto Rico – A Compelling Opportunity

Russian drones hit apartment block in Ukraine's Kharkiv, 46 hurt

American Axle & Manufacturing Holdings, Inc. (AXL) Q1 2025 Earnings Call Transcript

Leading Proxy Advisory Firm ISS Recommends Shareholders Vote FOR ONLY Tejon's 10 Director Nominees

Super Micro Q3 Preliminary Results: Stay Calm And Double Down (Upgrade)

Recent Posts

Tri Pointe Homes: The Firm's Deterioration Does Not Negate The Upside That It Offers

SmartRent Receives Continued Listing Standard Notice from NYSE

Recent Posts

Tri Pointe Homes: The Firm's Deterioration Does Not Negate The Upside That It Offers

SmartRent Receives Continued Listing Standard Notice from NYSE

Recent Posts

Tri Pointe Homes: The Firm's Deterioration Does Not Negate The Upside That It Offers

SmartRent Receives Continued Listing Standard Notice from NYSE

New Economy World News